175 related articles for article (PubMed ID: 37723456)
1. Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study.
Guillot P; Delamaire F; Gacouin A; Painvin B; Piau C; Reizine F; Lesouhaitier M; Tadié JM; Maamar A
BMC Infect Dis; 2023 Sep; 23(1):611. PubMed ID: 37723456
[TBL] [Abstract][Full Text] [Related]
2. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.
Garin N; Genné D; Carballo S; Chuard C; Eich G; Hugli O; Lamy O; Nendaz M; Petignat PA; Perneger T; Rutschmann O; Seravalli L; Harbarth S; Perrier A
JAMA Intern Med; 2014 Dec; 174(12):1894-901. PubMed ID: 25286173
[TBL] [Abstract][Full Text] [Related]
3. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
Griffin AT; Peyrani P; Wiemken T; Arnold F
Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
[TBL] [Abstract][Full Text] [Related]
4. Clinical Utility of Testing for Legionella Pneumonia in Central Texas.
Henry C; Boethel C; Copeland LA; Ghamande S; Arroliga AC; White HD
Ann Am Thorac Soc; 2017 Jan; 14(1):65-69. PubMed ID: 27739904
[TBL] [Abstract][Full Text] [Related]
5. The atypical pneumonias: clinical diagnosis and importance.
Cunha BA
Clin Microbiol Infect; 2006 May; 12 Suppl 3():12-24. PubMed ID: 16669925
[TBL] [Abstract][Full Text] [Related]
6. Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
Piso RJ; Arnold C; Bassetti S
Swiss Med Wkly; 2013; 143():w13870. PubMed ID: 24089030
[TBL] [Abstract][Full Text] [Related]
7. Community-acquired pneumonia and positive urinary antigen tests: Factors associated with targeted antibiotic therapy.
Mothes A; Léotard S; Nicolle I; Smets A; Chirio D; Rotomondo C; Tiger F; Del Giudice P; Perrin C; Néri D; Foucault C; Della Guardia M; Hyvernat H; Roger PM;
Med Mal Infect; 2016 Oct; 46(7):365-371. PubMed ID: 27377444
[TBL] [Abstract][Full Text] [Related]
8. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
Bartlett JG
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors, Management, and Outcomes of Legionella Pneumonia in a Large, Nationally Representative Sample.
Allgaier J; Lagu T; Haessler S; Imrey PB; Deshpande A; Guo N; Rothberg MB
Chest; 2021 May; 159(5):1782-1792. PubMed ID: 33352192
[TBL] [Abstract][Full Text] [Related]
10. Legionella pneumonia in the Niagara Region, Ontario, Canada: a case series.
Cargnelli S; Powis J; Tsang JL
J Med Case Rep; 2016 Dec; 10(1):336. PubMed ID: 27906087
[TBL] [Abstract][Full Text] [Related]
11. Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system.
Ito A; Ishida T; Washio Y; Yamazaki A; Tachibana H
BMC Pulm Med; 2017 Dec; 17(1):211. PubMed ID: 29246145
[TBL] [Abstract][Full Text] [Related]
12. Community-acquired Legionnaires' disease at a medical center in northern Taiwan.
Kao WF; Wang JT; Sheng WH; Chen YC
J Microbiol Immunol Infect; 2019 Jun; 52(3):465-470. PubMed ID: 28964650
[TBL] [Abstract][Full Text] [Related]
13. Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years.
Viasus D; Di Yacovo S; Garcia-Vidal C; Verdaguer R; Manresa F; Dorca J; Gudiol F; Carratalà J
Medicine (Baltimore); 2013 Jan; 92(1):51-60. PubMed ID: 23266795
[TBL] [Abstract][Full Text] [Related]
14. Severe community-acquired pneumonia due to Legionella pneumophila Serogroup 6.
Chen CY; Chen KY; Hsueh PR; Yang PC
J Formos Med Assoc; 2006 Mar; 105(3):256-62. PubMed ID: 16520845
[TBL] [Abstract][Full Text] [Related]
15. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
[TBL] [Abstract][Full Text] [Related]
16. Clinical and computed tomographic features of Legionella pneumonia with negative urine antigen test results.
Nakanishi M; Shiroshita A; Nakashima K; Takeshita M; Kiguchi T; Yamada H
Respir Investig; 2021 Mar; 59(2):204-211. PubMed ID: 33339738
[TBL] [Abstract][Full Text] [Related]
17. [Community-acquired pneumonia due to Legionella pneumophila serogroup 1. Study of 97 cases].
Benito JR; Montejo JM; Cancelo L; Zalacaín R; López L; Fernández Gil de Pareja J; Alonso E; Oñate J
Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):394-400. PubMed ID: 14525703
[TBL] [Abstract][Full Text] [Related]
18. Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-lactam-macrolide combination.
Karhu J; Ala-Kokko TI; Ohtonen P; Syrjälä H
Acta Anaesthesiol Scand; 2013 May; 57(5):587-93. PubMed ID: 23379766
[TBL] [Abstract][Full Text] [Related]
19. Distribution of Legionella species and serogroups in patients with culture-confirmed Legionella pneumonia.
Miyashita N; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kiyota H; Watanabe A
J Infect Chemother; 2020 May; 26(5):411-417. PubMed ID: 32081644
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study.
Ito A; Ishida T; Tachibana H; Nakanishi Y; Tokioka F; Yamazaki A; Washio Y; Irie H; Otake T
J Infect Chemother; 2021 Oct; 27(10):1447-1453. PubMed ID: 34147355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
